Joint Corp ( (JYNT) ) has released its Q3 earnings. Here is a breakdown of the information Joint Corp presented to its investors.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
The Joint Corp. is a leading national franchisor and operator of chiropractic clinics, offering accessible and affordable chiropractic care without the need for insurance. Known for its innovative retail healthcare model, the company has established a significant presence in the chiropractic industry with over 900 locations nationwide.
In its third-quarter earnings report for 2024, The Joint Corp. presented a mixed financial performance. While the company’s revenue grew by 2% to $30.2 million compared to the same quarter in 2023, it also reported a net loss of $3.2 million. This loss includes $3.8 million attributed to clinic disposition or impairment, highlighting challenges faced during their refranchising efforts.
Key financial metrics from the report reveal an 8% increase in system-wide sales to $129.3 million and a 4% growth in system-wide comparable sales. Despite these positive sales figures, the company experienced a decrease in adjusted EBITDA from $2.9 million to $2.4 million year-over-year. Additionally, The Joint Corp. expanded its clinic network, opening 14 new franchised clinics and refranchising one, although it also closed 11 clinics due to various operational reasons.
Looking ahead, The Joint Corp. remains committed to its strategic initiatives, including refranchising, enhancing clinic economics, and driving innovation to improve profitability. The management remains optimistic about navigating through near-term consumer challenges and is focused on sustaining growth and increasing shareholder value.
